26th Mar 2007 07:00
For immediate release 26 March 2007 LiDCO Group Plc ("the Company") Dates of preliminary announcement of results and of Annual General Meeting
LiDCO Group plc, the cardiovascular monitoring company, notifies the market that it will release the preliminary results of the Company for the year ended 31 January 2007 on 19 April 2007. The Annual General Meeting will be held on 2 July 2007.
There will be an analyst briefing at 10 am on 19 April 2007 at the offices of Buchanan Communications, 45 Moorfields, London, EC2. If you are interested in attending a briefing, please contact Buchanan on 0207 466 5000.
- ENDS -
For more information please contact:
LiDCO Group Plc Tel: +44 (0)20 7749 1500 Terry O'Brien - Chief Executive
Buchanan Communications Tel: +44 (0)20 7466 5000 Tim Anderson, James Strong Notes for EditorsAbout LiDCO Group Plc
LiDCO is a UK-based AIM-traded developer, manufacturer and leading supplier of minimally invasive, computer-based hemodynamic monitoring equipment and disposables used primarily for the management of critical care and cardiovascular risk hospital patients. Use of LiDCO's technology has been shown to significantly reduce the complications (particularly infections) and costs associated with major surgery. The technology was invented in the Department of Applied Physiology based at St Thomas' Hospital, London.
The Company's manufacturing facility is in Hoxton, London and its current products are:
¢â‚¬¢ LiDCOplus and PulseCO monitors: computer-based platforms for displaying a range of real-time, continuous hemodynamic parameters including cardiac output, oxygen delivery and fluid volume;
¢â‚¬¢ LiDCO disposables: used in conjunction with the LiDCOplus Monitor to accurately determine cardiac output in a minimally-invasive manner.
* LiDCOview - software product for use on a PC: designed to aide clinical,
audit, teaching and research activities.
Distribution Network:
The Company has now achieved registration of its products in 14 markets in Europe, the USA, Brazil and Japan. It sells direct in the UK and USA, and elsewhere through a worldwide network of specialty critical care distributors.
LIDCO GROUP PLCRelated Shares:
LID.L